Skip to main content

Tweets

🔶Clinical Year in Review #ACR24 🔶 Talk By @MHPillingerMD • Review some of the most impactful studies in Rheumatology from the past year! #RheumTwitter #Rheumatology https://t.co/1ULDB2l4gX
Mithu Maheswaranathan, MD @MithuRheum ( View Tweet )
1 year 2 months ago
The anti-MCTD group strikes back Of cohort of over 1,000 RNP+ pt, only 17 clinically diagnosed with MCTD Majority of patients, despite potential overlap, treated for other primary rheum dz @RheumNow #ACR24 https://t.co/vkQ6UPs34y
Brian Jaros, MD @Dr_Brian_MD ( View Tweet )
1 year 2 months ago
Older RA patients in RISE with high disease activity show a higher incidence of hip and major osteoporotic fractures. Practice T2T and monitor bone health closely! #ACR24 @RheumNow ABST#1748 https://t.co/7MCAIrfXhp
Jiha Lee @JihaRheum ( View Tweet )
1 year 2 months ago
Phase 2 RCT of MK2 inhibitor did not show clinical efficacy at week 12 in active AS pts compared to PBO. There are still unmet needs for additional therapeutics in pts with AS that not respond to current therapies. Abst#1760 #ACR24 @RheumNow https://t.co/cXv8HYr0Xr
Adela Castro @AdelaCastro222 ( View Tweet )
1 year 2 months ago
Comparison of infection risk across b/tsDMARDs in IA in real-world study Treatment with ➡️Rituximab ➡️JAKi ➡️Anti-IL6 assoc with ⬆️⬆️ risk of severe infection compared to TNFi A reminder to consider comorbidities & infection risk in selecting b/tsDMARDs Ab1716 #ACR24 @RheumNow

Mrinalini Dey @DrMiniDey ( View Tweet )

1 year 2 months ago
RCTs are the gold standard in drug research, but rising placebo (PBO) response rates with global recruitment could distort treatment effects. Limited access to care in less affluent countries may be a factor. #ACR24 @RheumNow ABST#1746 https://t.co/fVeNcw5qwO
Jiha Lee @JihaRheum ( View Tweet )
1 year 2 months ago
SURPASS trial of bio naïve axSpA at risk of radiographic progression: 1. Presence of syndesmophytes 2. Higher CRP levels 3. Higher ASDAS 4. Higher spinal MRI BME scores Were predictors of spinal progression independent of ttnt Abst#1759 #ACR24 @RheumNow https://t.co/QC9FMPufPY
Adela Castro @AdelaCastro222 ( View Tweet )
1 year 2 months ago
How does #race & #ethnicity impact mortality in RA? Study in CDC national mortality database ➡️RA mortality differed by race & ethnicity ➡️Highest premature mortality in Native Americans Findings may be used to inform resource allocation & management Ab1747 #ACR24 @RheumNow

Mrinalini Dey @DrMiniDey ( View Tweet )

1 year 2 months ago
In this systematic review & metaanalyis by Dr. RFarhat et al, tacrolimus whole blood levels decrease in the 1st & 2nd trimesters then increase back to pre-pregnancy levels postpartum. Needs further studies to guide dose adjustment. @RheumNow #ACR24 abs1535 https://t.co/5MovzPJoFc
1 year 2 months ago
Dr. BDinneen et al reported predictors that can help screen axSpA pts w/o traditional CV RFs for carotid doppler utz: - shorter dse duration - no family hx of IHD - HLAB27+ - ⬆️ dBP, WHratio, ferritin, TC, LDL and TC:HDL ratio Small size, more data reqd @RheumNow #ACR24 abs1440 https://t.co/3pZxFmutJz
1 year 2 months ago
Andreasson et al. High intensity interval training provides greater improvements in exercise capacity than standard moderate intensity training in IIM. @RheumNow #ACR24 Abstr#1735 https://t.co/baj7Cq2QjO https://t.co/yiE1vuk2me
Richard Conway @RichardPAConway ( View Tweet )
1 year 2 months ago
A#1748 Fracture incidence in RA - RISE registry Incidence rate of MOF, hip Fx by disease activity 50% did not have CDAI available IR 12 per 1000py hip, 43 for MOF High activity worst, low/mod similar, remission is best Supports remission is better than LDA @RheumNow #ACR24 https://t.co/78FCLemfZD
Eric Dein @ericdeinmd ( View Tweet )
1 year 2 months ago
×